Harsh economic conditions and increased competition are dictating that surgical robotics companies must quickly adopt new commercial strategies. In Vivo speaks to key players in the space to learn more.

GE HealthCare’s newly FDA-cleared Portrait Mobile enables real-time continuous wireless monitoring of patient vital signs such as respiration rate.

Many use cases potentially suit AliveCor’s smartphone-based ECG device, which delivers medical-grade cardiac data to consumers, patients and doctors on demand. Artificial intelligence is just one element of the technology offering, says the company’s VP, EMEA Stefan Holzer.

System interoperability and building trust in AI capabilities are central to the strategic collaboration and organic growth plans at GE HealthCare, according to US and Canada regional president and CEO Catherine Estrampes, who spoke to In Vivo as the company released the findings of a major survey of clinicians and patients on future healthcare system needs.